HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jacob Allred Selected Research
Jacob Allred Research Topics
Disease
3
Neoplasms (Cancer)
04/2024 - 06/2007
2
Multiple Myeloma
08/2011 - 01/2006
1
Immunoglobulin Light-chain Amyloidosis
05/2012
1
Amyloidosis
05/2012
1
Melanoma (Melanoma, Malignant)
06/2007
1
Neoplasm Metastasis (Metastasis)
06/2007
1
Anemia
07/2006
1
Portal Hypertension
07/2006
1
Splenomegaly
07/2006
1
Thrombocytopenia (Thrombopenia)
07/2006
1
Thrombocytosis (Thrombocythemia)
07/2006
1
Primary Myelofibrosis (Myelosclerosis)
07/2006
Drug/Important Bio-Agent (IBA)
2
Dexamethasone (Maxidex)
FDA Link
Generic
05/2012 - 08/2011
2
Cyclophosphamide (Cytoxan)
FDA Link
Generic
05/2012 - 08/2011
2
Lenalidomide (CC 5013)
FDA Link
05/2012 - 08/2011
1
Gemcitabine
FDA Link
04/2024
1
ribociclib
IBA
04/2024
1
Epidermal Growth Factor (EGF)
IBA
01/2019
1
tipifarnib (R115777)
IBA
01/2019
1
Erlotinib Hydrochloride (CP 358,774)
FDA Link
01/2019
1
Tyrosine Kinase Inhibitors
IBA
01/2019
1
Farnesyltranstransferase (Farnesyltransferase)
IBA
01/2019
1
Alkylating Agents
IBA
05/2012
1
Biomarkers (Surrogate Marker)
IBA
06/2007
1
Thrombospondins
IBA
06/2007
1
Angiogenesis Inducing Agents (Angiogenesis Factor)
IBA
06/2007
1
NAc- Sar- Gly- Val- (d- allo- Ile)- Thr- Nva- Ile- Arg- ProNEt (ABT 510)
IBA
06/2007
1
Imatinib Mesylate (Gleevec)
FDA Link
01/2006
Therapy/Procedure
1
Splenectomy
07/2006
1
Blood Component Removal (Apheresis)
07/2006